2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide

C43H48F3N7O5S — CID 159069978

IUPAC2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide
SMILESCC(C)Cc1cc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)ccc1OCCN1CCN(CC(=O)Nc2cccc(NC3CCC(=O)CC3=O)c2)CC1
InChIInChI=1S/C43H48F3N7O5S/c1-27(2)20-29-21-33(53-41(59)52(40(57)42(53,3)4)32-9-8-28(25-47)35(23-32)43(44,45)46)10-13-38(29)58-19-18-50-14-16-51(17-15-50)26-39(56)49-31-7-5-6-30(22-31)48-36-12-11-34(54)24-37(36)55/h5-10,13,21-23,27,36,48H,11-12,14-20,24,26H2,1-4H3,(H,49,56)
InChIKeyJZNGIRARHFAOCY-UHFFFAOYSA-N
MW831.96 g/mol
LogP6.43
Rot. Bonds13

About 2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide

2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide (PubChem CID 159069978) has the molecular formula C43H48F3N7O5S and a molecular weight of 831.96 g/mol. Its IUPAC name is 2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide.

Molecular Properties

Compound Name2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide
PubChem CID159069978
Molecular FormulaC43H48F3N7O5S
Molecular Weight831.96 g/mol
Exact Mass831.34
IUPAC Name2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide
SMILESCC(C)Cc1cc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)ccc1OCCN1CCN(CC(=O)Nc2cccc(NC3CCC(=O)CC3=O)c2)CC1
InChIInChI=1S/C43H48F3N7O5S/c1-27(2)20-29-21-33(53-41(59)52(40(57)42(53,3)4)32-9-8-28(25-47)35(23-32)43(44,45)46)10-13-38(29)58-19-18-50-14-16-51(17-15-50)26-39(56)49-31-7-5-6-30(22-31)48-36-12-11-34(54)24-37(36)55/h5-10,13,21-23,27,36,48H,11-12,14-20,24,26H2,1-4H3,(H,49,56)
InChIKeyJZNGIRARHFAOCY-UHFFFAOYSA-N
XLogP6.43
TPSA138.32 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds13
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500831.96
LogP ≤ 56.43
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze 2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide?
The IUPAC name of 2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide (CID 159069978) is 2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide.
What is the SMILES notation for 2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide?
The canonical SMILES for 2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide is CC(C)Cc1cc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)ccc1OCCN1CCN(CC(=O)Nc2cccc(NC3CCC(=O)CC3=O)c2)CC1.
What is the InChIKey of 2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide?
The InChIKey is JZNGIRARHFAOCY-UHFFFAOYSA-N. The full InChI is InChI=1S/C43H48F3N7O5S/c1-27(2)20-29-21-33(53-41(59)52(40(57)42(53,3)4)32-9-8-28(25-47)35(23-32)43(44,45)46)10-13-38(29)58-19-18-50-14-16-51(17-15-50)26-39(56)49-31-7-5-6-30(22-31)48-36-12-11-34(54)24-37(36)55/h5-10,13,21-23,27,36,48H,11-12,14-20,24,26H2,1-4H3,(H,49,56).
What are the key properties of 2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide?
2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide has a molecular weight of 831.96 g/mol, XLogP of 6.43, 13 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[2-[4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(2-methylpropyl)phenoxy]ethyl]piperazin-1-yl]-N-[3-[(2,4-dioxocyclohexyl)amino]phenyl]acetamide is sourced from PubChem (CID 159069978), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).